Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,611.07
(
0.15%
)
US TECH 100
29,810.80
(
0.34%
)
Dow Jones
51,168.32
(
0.18%
)
Brent Oil
94.91
(
-1.10%
)
Bitcoin
67,688.01
(
-5.16%
)
News Focus
News Focus
Post# of 519081
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

XenaLives

Member Level

Re: None

Thursday, 11/29/2018 9:41:29 AM

Thursday, November 29, 2018 9:41:29 AM

Post# of 519081
IMO - on approval 2-73 will be the only viable treatment for Alzheimer's.

Within a year of approval Anavex could also be a major player, if not dominant, in the CNS and psychiatric space.

Does anyone know of another drug that has moved into the market with such force?

I'd like to look at that history...



In Peace, In War

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News